💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Arrowhead Research Corporation (ARWR)
« Back to company indexARWR Chatter Timeline
Stock Ticker for ARWR
Most Active Tweeters for ARWR
| User | Tweets |
|---|---|
| @portefeuillefun | 26 |
| @pt117cool | 20 |
| @BikeRieder | 16 |
| @truthtracer | 13 |
| @Gambiste1 | 13 |
Recent Tweets for ARWR
 |
@truthtracer @ByMadeleineA Assuming you’ve figured that out as opposed to feigning inexplicable ignorance. It’s a much better look. $ARWR $VRTX October 19th 2020, 5:10pm |
 |
@mhrob RT @truthtracer: Nice to see that others are becoming aware of the $ARWR bigger picture perspective. It’s no longer a unique point of view.… October 19th 2020, 5:10pm |
|
@truthtracer Nice to see that others are becoming aware of the $ARWR bigger picture perspective. It’s no longer a unique point o… https://t.co/aSslNE8EI1 October 19th 2020, 5:10pm |
|
@truthtracer @PersimmonTI $ARWR Showed good relative strength (as a fundamental influence here) where external market influence… https://t.co/KT30rYD3Q1 October 19th 2020, 4:10pm |
 |
@Gambiste1 RT @ahighelevation: $ARWR Collaboration with Takeda for Orphan Liver Disease Treatment #liverhealth #biotech #smallcap - https://t.co/BQ1K… October 19th 2020, 3:10pm |
 |
@ahighelevation $ARWR Collaboration with Takeda for Orphan Liver Disease Treatment #liverhealth #biotech #smallcap -… https://t.co/GNLdwlaBLQ October 19th 2020, 1:10pm |
 |
@PersimmonTI RT @truthtracer: @PersimmonTI $ARWR receiving constant exposure. The market reacted to the $VRTX #A1AD misstep & there’s direct correlation… October 19th 2020, 1:10pm |
 |
@wisdomofthetape $ARWR setting up. October 19th 2020, 1:10pm |
 |
@Endo1W RT @kkernttb: $ARWR nice setup on watch https://t.co/WAaT3us44T October 19th 2020, 1:10pm |
|
@truthtracer @PersimmonTI $ARWR receiving constant exposure. The market reacted to the $VRTX #A1AD misstep & there’s direct corr… https://t.co/ATUqZ03yRq October 19th 2020, 12:10pm |
|
@PersimmonTI $ARWR Volume really picking up... October 19th 2020, 11:10am |
 |
@pt117cool RT @pt117cool: $ARWR - All Aboard the TRIM TRAIN..leaving from track 49 and where WERE GOING, there is no ROADS. BUCKLE UP..The ride should… October 19th 2020, 11:10am |
 |
@mellowrk_lion For those asking abt $ARWR I only joined twitter end of July and started posting in Aug. This buy was b4 I started… https://t.co/x7qovI3VZW October 19th 2020, 11:10am |
 |
@Sqwii $ARWR another example showing why some bios can be fun to own when they start to run - from 2017 to 2019s https://t.co/FOIL0YDfV1 October 19th 2020, 11:10am |
 |
@kkernttb $ARWR nice breakout in the works... moves around https://t.co/y7l5cnit8b October 19th 2020, 11:10am |
 |
@TraderAnthony88 $ARWR on fire today. Looks like we'll finally get our $50+ closing price October 19th 2020, 11:10am |
|
@kkernttb $ARWR nice setup on watch https://t.co/WAaT3us44T October 19th 2020, 11:10am |
 |
@danshep55 $ARWR 51.50 needs a new base to stretch October 19th 2020, 10:10am |
 |
@joetrader87 $ARWR The slow buying and raising of bid and hitting ask TELLS all October 19th 2020, 10:10am |
|
@joetrader87 $ARWR Shorts are totally TOAST! October 19th 2020, 10:10am |
|
@pt117cool $ARWR - All Aboard the TRIM TRAIN..leaving from track 49 and where WERE GOING, there is no ROADS. BUCKLE UP..The ride should be a BLAST. October 19th 2020, 9:10am |
 |
@ThomasPhilipp6 RT @BikeRieder: $ARWR Today FDA decision about SEQUOIA? October 19th 2020, 8:10am |
 |
@MarketTrendAdv $ARWR - And @ArrowheadPharma CEO Chris Anzalone has been a small molecule skeptic (for several indications).… https://t.co/utcT5uYcGQ October 19th 2020, 8:10am |
|
@MarketTrendAdv $ARWR - @SVBLeerink REVISE I say! ? https://t.co/1PM6fxQRut October 19th 2020, 7:10am |
|
@pt117cool RT @ozzy_jozzy: @TraderAnthony88 $ARWR never concerned about $VRTX AAT program to begin with. Small molecule approach dead on arrival, Expl… October 19th 2020, 7:10am |
|
@pt117cool RT @AHVReds: A 9% short float in $ARWR is better known as financial suicide October 19th 2020, 7:10am |
 |
@BikeRieder $ARWR Today FDA decision about SEQUOIA? October 19th 2020, 7:10am |
 |
@chiragontwtr @Biotech2k1 $ARWR is not for sale. Arrowhead's CEO in Jan-2020: "It would shock me if anybody could write a big e… https://t.co/0yuzFHsSkD October 19th 2020, 12:10am |
 |
@RichUSA123 RT @MarketTrendAdv: $ARWR - Peeps missing the gap potential (red arrows) on a breach of $53.20. I think this name "goes" just like our bea… October 18th 2020, 6:10pm |
|
@MarketTrendAdv $ARWR - Peeps missing the gap potential (red arrows) on a breach of $53.20. I think this name "goes" just like our… https://t.co/NZar03XZP9 October 18th 2020, 6:10pm |
 |
@DinoPerlman @The_Ravid @Biotech2k1 Isn't crispr still basically preclinical with their CF program? $ARWR October 18th 2020, 4:10pm |
 |
@Tickeron $ARWR's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/2GpFR5fhiW October 18th 2020, 11:10am |
 |
@3IDWarrant @Biotech2k1 Disagree that $ARWR could be had for less than $CRSP while the market doesn't like to give MC Credit t… https://t.co/BMDuCETuG4 October 18th 2020, 7:10am |
 |
@Biotech2k1 I think $VRTX should just buy $ARWR. They would get a far more advance pipeline at a later stage of development. Th… https://t.co/4Eclt9gKHy October 18th 2020, 6:10am |
|
@1243MN21t @RNAiPhD Prophylactic use of $ARWR ARO-COV for CV19 would be an impressive advancement for RNAi drug development. I… https://t.co/p19VxcjOKn October 18th 2020, 3:10am |
|
@Endo1W RT @buyhighSelhiger: $ARWR indecision break out target looks: highly likelihood of a break out https://t.co/rPCjos1y0s October 17th 2020, 10:10pm |
 |
@buyhighSelhiger $ARWR indecision break out target looks: highly likelihood of a break out https://t.co/rPCjos1y0s October 17th 2020, 7:10pm |
 |
@Rwarner42 RT @PersimmonTI: $ARWR $VRTX It may require more than a molecule to modify disease pathology: https://t.co/uAqdferaRn October 17th 2020, 11:10am |
|
@PersimmonTI $ARWR $VRTX It may require more than a molecule to modify disease pathology: https://t.co/uAqdferaRn October 17th 2020, 11:10am |
 |
@Hall8Jack RT @PersimmonTI: $VRTX $ARWR Vertex claims VX-864 is structurally distinct from 814, with increased potency, so it could well be that the… October 17th 2020, 11:10am |
|
@PersimmonTI $VRTX $ARWR Vertex claims VX-864 is structurally distinct from 814, with increased potency, so it could well be th… https://t.co/yE42uJnKgd October 17th 2020, 11:10am |
|
@BikeRieder RT @PersimmonTI: $VRTX $ARWR It may not just be about the molecule — it may be about the modality. In AATD, for starters. Much more to c… October 17th 2020, 9:10am |
|
@PersimmonTI $VRTX $ARWR It may not just be about the molecule — it may be about the modality. In AATD, for starters. Much mo… https://t.co/9hHkcxoX2W October 17th 2020, 9:10am |
 |
@TheMarketsDaily Arrowhead Pharmaceuticals Inc $ARWR Director Mauro Ferrari Sells 10,000 Shares https://t.co/xeWhhuL1kS October 17th 2020, 7:10am |
 |
@ozzy_jozzy @BuffSoldierTwo @jerchess $ARWR I think I see him in there a couple of times...once tearing up a cheque (not big en… https://t.co/QrlYR2YMud October 16th 2020, 9:10pm |
 |
@WallStPirate $ARWR From Only ARWR on YMB. ALNY ALN-AAT02 was terminated September stating sponsor did not proceed with Part B… https://t.co/dINAvqdrXL October 16th 2020, 8:10pm |
 |
@BuffSoldierTwo @jerchess $ARWR I’m sure he’s here somewhere https://t.co/E0lmNU7Z9P October 16th 2020, 8:10pm |
 |
@jerchess $ARWR where is Chris? ????? October 16th 2020, 5:10pm |
 |
@MarkC53916729 $VRTX VX-814 is an #RNAi killer "for sure" $ARWR https://t.co/fG7hXIALYF October 16th 2020, 5:10pm |
|
@pt117cool RT @pt117cool: $ARWR - We have had great news the last 3 weeks, SI is up (Way to high), talk of trying to get us under $45 Options by next… October 16th 2020, 3:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
